Results 61 to 70 of about 18,931 (219)

Approach to atherosclerotic renovascular disease: 2016 [PDF]

open access: yes, 2016
The management of atherosclerotic renal artery stenosis in patients with hypertension or impaired renal function remains a clinical dilemma. The current general consensus, supported by the results of the Angioplasty and Stenting for Renal Atherosclerotic
Daloul, Reem, Morrison, Aubrey R
core   +2 more sources

Multimodal imaging approach in hyponatremic hypertensive syndrome. A rare case of pediatric unilateral hypoplasia of the main renal artery combined itself with stenosis and review of literature

open access: yesRadiology Case Reports, 2023
Renal artery stenosis (RAS) accounts for approximately 5%-10% of secondary renovascular hypertension in the pediatric population. It can occur as an isolated entity, or as a hypoplasia combined itself with stenosis.
Angela Siervo, MD   +7 more
doaj   +1 more source

Ex vivo perfusion, arteriography, and autotransplantation procedures for kidney salvage [PDF]

open access: yes, 1973
Three kidneys with arterial lesions that would have been difficult or impossible to repair by standard vascular reconstruction were removed, perfused by the Belzer technique, and returned to host after partial or complete autotransplantation.
Anderson, JT   +6 more
core  

Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]

open access: yes, 2011
<p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H.   +10 more
core   +1 more source

Renovascular hypertension in neurofibromatosis [PDF]

open access: yesPostgraduate Medical Journal, 1989
Summary We present two patients with renovascular hypertension in association with neurofibromatosis. In both cases the diagnosis was established by angiography. The first patient suffered occlusion of the right renal artery combined with intrarenal arterial lesions. Treatment was by autotransplantation.
S G, Pollard   +3 more
openaire   +2 more sources

Pre‐Emptive Amlodipine for FOLFIRINOX‐Induced Hypertensive Crises Without Primary Hypertension: A Novel Chronotherapeutic Strategy

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT FOLFIRINOX remains a cornerstone therapy for advanced pancreatic ductal adenocarcinoma (PDAC), but its toxicity profile extends beyond myelosuppression and neuropathy to include even rarer complications such as treatment‐associated hypertension.
Manas Pustake   +4 more
wiley   +1 more source

Surgical treatment of renovascular hypertension in children

open access: yesThe Turkish Journal of Pediatrics, 1991
Hypertension of renovascular origin in pediatric patients is frequently encountered. Herein, we review our experience, as well as that of others, with this type of patient, and discuss the characteristic features of renovascular hypertension and ...
I Paşaoğlu   +3 more
doaj  

Adult‐Onset Bartter Syndrome Presenting as Refractory Hypokalemia and Metabolic Alkalosis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Bartter syndrome (BS) is a rare autosomal recessive salt‐wasting tubulopathy characterized by hypokalemic metabolic alkalosis, hyperreninemia, and hyperaldosteronism without hypertension. It usually presents in childhood; however, adult‐onset cases are infrequent and often misdiagnosed.
Muhammad Asif   +7 more
wiley   +1 more source

Arterial Stiffness in a Toddler with Neurofibromatosis Type 1 and Refractory Hypertension

open access: yesCase Reports in Pediatrics, 2018
Arterial hypertension is a common finding in patients with neurofibromatosis (NF) type 1. Renovascular hypertension due to renal artery stenosis or midaortic syndrome could be the underlying cause.
Stella Stabouli   +7 more
doaj   +1 more source

Comparative effectiveness of combination therapy with SGLT‐2 inhibitors and GLP‐1 RAs compared with SGLT‐2 inhibitors in individuals with type 2 diabetes: A prevalent new‐user cohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3273-3284, April 2026.
Abstract Aims To evaluate the effectiveness of combination therapy with sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) compared with continued SGLT‐2 inhibitor therapy in routine practice among individuals with type 2 diabetes.
Gregor A. Maier   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy